Center for Cell and Organ Biotechnology Hosts Enlightening Scientific Symposium

COLLEGE STATION, TX, JULY 21 – Last Friday, a panel of Center for Cell and Organ Biotechnology (CCOB) participants convened for a one-day scientific symposium at the Texas A&M Institute of Preclinical Studies. Topics ranged from Texas Heart Institute’s molecular cardiology research programs and clinical studies in stem cell therapy to commercialization strategies for early stage biotechnology.

The CCOB, supported by Texas Emerging Technology Fund, is a new collaboration between the Texas A&M College of Veterinary Medicine & Biomedical Sciences (CVM) in College Station and Texas Heart Institute (THI) in Houston. Led by Dr. Doris Taylor, director of the CCOB and director of Regenerative Medicine Research at THI, the center includes scientists, engineers, physicians, veterinarians, and business managers from both organizations and other colleges located at Texas A&M University.

“It was exciting to be together in College Station with representatives of all aspects of the CCOB including the Oversight Board, the External Commercialization Advisory Group (ECAG), and CCOB participants,” Taylor said. “This was a chance for all invited to share their knowledge and formulate new ideas for potential collaborations leading to commercialization.”

Presenters at the symposium included Taylor, members of the CCOB Oversight Board, Dr. Eleanor Green, dean of the College of Veterinary Medicine & Biomedical Sciences, and Dr. James T. Willerson, president and medical director of THI.

“With this symposium, our goal was to educate each other about facilities available to the CCOB at both institutions,” Taylor continued. “We strove to empower our faculty to innovate, translate those innovations for patient benefit, and train the next generation of scientists and innovators.”

Taylor draws from expertise at both institutions to position the CCOB as a world leader in adult stem cell research, organ transplantation, and personalized medicine. Launched in 2013, the CCOB has grown considerably by recruiting distinguished scientists from out of state to both Texas A&M and THI, as well as life sciences industry executives to provide input on the ECAG.

“True to the Texas Emerging Technology Fund mission for a research superiority award, research talent abounds within the CCOB,” Green said. “With two world-class organizations, the Texas Heart Institute and the Texas A&M College of Veterinary Medicine & Biomedical Sciences, joining forces, the CCOB is destined to make a difference for human patients, animal patients, and the world they share by building the medicines of tomorrow.”

###

For more information about the Center for Cell and Organ Biotechnology, please visit our website at www.ccobtexas.org.

For more information about the Texas A&M CVM, please visit our website at vetmed.tamu.edu or join us on Facebook.

For more information, contact:

Dr. Megan Palsa
mpalsa@cvm.tamu.edu
979-862-4216
979-421-3121 (cell)